Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Luca Grassano"'
Autor:
Sverdlov O; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Berger VW; National Institutes of Health, Bethesda, Maryland, USA., Carter K; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA.
Publikováno v:
Pharmaceutical statistics [Pharm Stat] 2024 May-Jun; Vol. 23 (3), pp. 425-428. Date of Electronic Publication: 2024 Jan 14.
Autor:
Ilaria Galgani, Airi Põder, Rain Jõgi, Veli-Jukka Anttila, Stefano Milleri, Alberto M. Borobia, Odile Launay, Marco Testa, Daniela Casula, Luca Grassano, Annaelisa Tasciotti, Marie Dozot, Ashwani K. Arora
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 1 (2023)
A candidate AS01-adjuvanted vaccine containing four surface proteins from non-typable Haemophilus influenzae and Moraxella catarrhalis (NTHi-Mcat) has been developed to help prevent exacerbations of chronic obstructive pulmonary disease (COPD). Seque
Externí odkaz:
https://doaj.org/article/a22f2fc2d4424a7484a23d2c14b24cde
Publikováno v:
Pharmaceutical Statistics. 22:570-576
Autor:
Torri D. Metz, Immaculada Margarit, Ouzama Henry, James D. Campbell, Richard H. Beigi, Giada Buffi, David E. Soper, Annette Dreisbach, Maria Lattanzi, Luca Grassano, Zourab Bebia, Annette Karsten, Kathryn M. Edwards, Geeta K. Swamy
Publikováno v:
Vaccine. 38(44)
Background This study evaluated the safety and immunogenicity of an investigational trivalent group B streptococcus (GBS) vaccine in US pregnant women, transplacental serotype-specific antibody transfer and persistence in infants, and serotype-specif
Autor:
Annelies Aerssens, Ouzama Henry, Cathy Maes, Immaculada Margarit, Geert Leroux-Roels, Giada Buffi, A. Karsten, Luca Grassano, Karen S. Slobod, Stephen Cho, Fien De Boever, Bartholomew Corsaro, Zourab Bebia
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background Maternal immunization against group B streptococcus (GBS) could protect infants from invasive GBS disease. Additional doses in subsequent pregnancies may be needed. We evaluated the safety and immunogenicity of a second dose of an investig
Autor:
Fernando Rizzello, Andrea Cassinotti, Guido Pagana, Marco Daperno, Alessandro Armuzzi, Luca Grassano, Livia Biancone, R. Cosintino, Roberta Pica, Michele Comberlato, Renata D'Incà, Alfredo Papa, Roberto Mangiarotti, Andrea Bonanomi, Ambrogio Orlando, Giovanni Lombardi, Fabrizio Bossa
Backgrounds and Aims: Endoscopic outcomes are increasingly used in clinical trials and in routine practice for inflammatory bowel disease [IBD] in order to reach more objective patient evaluations than possible using only clinical features. However,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f0ec32433dcdea47b9c75309dbafa98
http://hdl.handle.net/2108/217342
http://hdl.handle.net/2108/217342
Publikováno v:
Biometrical journal. Biometrische Zeitschrift. 60(1)
In clinical research and in more general classification problems, a frequent concern is the reliability of a rating system. In the absence of a gold standard, agreement may be considered as an indication of reliability. When dealing with categorical
Autor:
Ovbude, Leroy Jide1 (AUTHOR) leroyjide.x.ovbude@gsk.com, Grassano, Luca2 (AUTHOR), Cheuvart, Brigitte1 (AUTHOR), Solmi, Francesca1 (AUTHOR)
Publikováno v:
Statistics in Biopharmaceutical Research. Oct-Dec2024, Vol. 16 Issue 4, p491-497. 7p.
Autor:
Luca Grassano, R. Cosintino, Roberta Pica, Ambrogio Orlando, Giovanni Lombardi, Marco Daperno, Livia Biancone, Andrea Bonanomi, Matteo Rabagliati, Fernando Rizzello, Alfredo Papa, Roberto Mangiarotti, Guido Pagana, Fabrizio Bossa, Mauro Gasparini, Renata D'Incà, Michele Comberlato
Publikováno v:
Gastroenterology. 150:S983-S984
Publikováno v:
Pharmaceutical Statistics; May2023, Vol. 22 Issue 3, p570-576, 7p